Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) COO Tina Marriott Larson sold 3,000 shares of the stock in a transaction that occurred on Thursday, June 29th. The stock was sold at an average price of $7.49, for a total transaction of $22,470.00. Following the completion of the transaction, the chief operating officer now owns 424,160 […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) shares fell 3.9% during trading on Friday after an insider sold shares in the company. The stock traded as low as $8.35 and last traded at $8.43. 724,610 shares were traded during mid-day trading, a decline of 49% from the average session volume of 1,433,050 shares. The stock […]
Recursion Pharmaceuticals (NASDAQ:RXRX – Get Rating) posted its earnings results on Monday. The company reported ($0.34) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.01, MarketWatch Earnings reports. Recursion Pharmaceuticals had a negative return on equity of 53.07% and a negative net margin of 601.05%. The business had revenue […]